| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 61.3621 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 61.3621. The average price that SDZ.SW shares were previous bought at was CHF 44.1701. The current market price is 38.9% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 103,493 (USD $128,627) compared to the previous valuation of however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 123.5 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 123.5. The average price that IPN.PA shares were previous bought at was EUR 103.683. The current market price is 19.1% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 18,650 (USD $21,648) compared to the previous valuation of Ipsen SA |
| LONN.SW - | HOLD | 0 @ CHF 593.274 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 593.274. The average price that LONN.SW shares were previous bought at was CHF 606.416. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 52,185 (USD $64,858) compared to the previous valuation of |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 116.75 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 116.75. The average price that MRK.DE shares were previous bought at was EUR 115.858. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 5,501 (USD $6,385) compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 113.729 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 113.729. The average price that NOVN.SW shares were previous bought at was CHF 101.338. The current market price is 12.2% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 1,628,366 (USD $2,023,821) compared to the previous valuation of however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 41.1121 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 41.1121. The average price that NOVO-B.CO shares were previous bought at was DKK 63.2354. The current market price is -35.0% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 1,351,907 (USD $210,134) compared to the previous valuation of Novo Nordisk A/S |
| NSIS-B.CO - | HOLD | 0 @ DKK 52.8479 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 52.8479. The average price that NSIS-B.CO shares were previous bought at was DKK 61.0647. The current market price is -13.5% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has fallen by DKK 140,997 (USD $21,916) compared to the previous valuation of |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 61.3 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 61.3. The average price that ORNBV.HE shares were previous bought at was EUR 60.1932. The current market price is 1.8% higher than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 24.23 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 24.23. The average price that PHIA.AS shares were previous bought at was EUR 21.0294. The current market price is 15.2% higher than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 79,728 (USD $92,546) compared to the previous valuation of Koninklijke Philips NV |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 40.405 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 40.405. The average price that QIA.DE shares were previous bought at was EUR 42.5094. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 53,690 (USD $62,322) compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 49.52 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 49.52. The average price that REC.MI shares were previous bought at was EUR 53.4467. The current market price is -7.3% lower than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 39,015 (USD $45,287) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| ROG.SW - | HOLD | 0 @ CHF 335.51 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 335.51. The average price that ROG.SW shares were previous bought at was CHF 281.464. The current market price is 19.2% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 1,298,561 (USD $1,613,921) compared to the previous valuation of however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 86.15 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 86.15. The average price that SAN.PA shares were previous bought at was EUR 88.9526. The current market price is -3.2% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 213,044 (USD $247,294) compared to the previous valuation of Sanofi SA |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.19513 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.19513. The average price that HLN.L shares were previous bought at was GBP 4.56586. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 271,853 (USD $359,100) compared to the previous valuation of Haleon PLC |
| SECT-B.ST - | HOLD | 0 @ SEK 25.2796 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 25.2796. The average price that SECT-B.ST shares were previous bought at was SEK 29.0373. The current market price is -12.9% lower than average price they were purchased at. The value of the holding in SECT-B.ST has fallen by SEK 25,198 (USD $2,666) compared to the previous valuation of |
| SFZN.SW - | HOLD | 0 @ CHF 76.89 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 76.89. The average price that SFZN.SW shares were previous bought at was CHF 105.102. The current market price is -26.8% lower than average price they were purchased at. The value of the holding in SFZN.SW has fallen by CHF 19,006 (USD $23,622) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 42.67 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 42.67. The average price that SHL.DE shares were previous bought at was EUR 47.9251. The current market price is -11.0% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 11,094 (USD $12,878) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.0369 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.0369. The average price that SN.L shares were previous bought at was GBP 12.7572. The current market price is 10.0% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 51,782 (USD $68,401) compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 30.8283 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 30.8283. The average price that SOBI.ST shares were previous bought at was SEK 26.4967. The current market price is 16.3% higher than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 27,365 (USD $2,895) compared to the previous valuation of |
| SOON.SW - | HOLD | 0 @ CHF 215.892 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 215.892. The average price that SOON.SW shares were previous bought at was CHF 271.632. The current market price is -20.5% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 43,966 (USD $54,643) compared to the previous valuation of |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 248.2 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 248.2. The average price that SRT3.DE shares were previous bought at was EUR 215.217. The current market price is 15.3% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 2,131 (USD $2,474) compared to the previous valuation of Sartorius AG |
| STMN.SW - | HOLD | 0 @ CHF 98.5221 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 98.5221. The average price that STMN.SW shares were previous bought at was CHF 113.693. The current market price is -13.3% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 57,798 (USD $71,834) compared to the previous valuation of |
| TECN.SW - | HOLD | 0 @ CHF 145.32 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 145.32. The average price that TECN.SW shares were previous bought at was CHF 178.532. The current market price is -18.6% lower than average price they were purchased at. The value of the holding in TECN.SW has fallen by CHF 15,238 (USD $18,939) compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 211 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 211. The average price that TUB.BR shares were previous bought at was EUR 128.453. The current market price is 64.3% higher than average price they were purchased at. The value of the holding in TUB.BR has fallen by EUR 9,029 (USD $10,481) compared to the previous valuation of Financiere de Tubize SA |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 243 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 243. The average price that UCB.BR shares were previous bought at was EUR 162.822. The current market price is 49.2% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 179,180 (USD $207,986) compared to the previous valuation of UCB SA however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 65.2866 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 65.2866. The average price that ZEAL.CO shares were previous bought at was DKK 58.9926. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 16,369 (USD $2,544) compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 29.0282 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 29.0282. The average price that DEMANT.CO shares were previous bought at was DKK 35.6031. The current market price is -18.5% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 11,174 (USD $1,737) compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 68.0445 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.0445. The average price that ALC.SW shares were previous bought at was CHF 77.6685. The current market price is -12.4% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 56,785 (USD $70,575) compared to the previous valuation of |
| ALK-B.CO - | HOLD | 0 @ DKK 31.0633 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 31.0633. The average price that ALK-B.CO shares were previous bought at was DKK 23.6007. The current market price is 31.6% higher than average price they were purchased at. The value of the holding in ALK-B.CO has fallen by DKK 12,075 (USD $1,877) compared to the previous valuation of |
| AMBU-B.CO - | HOLD | 0 @ DKK 11.5684 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 11.5684. The average price that AMBU-B.CO shares were previous bought at was DKK 13.8673. The current market price is -16.6% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has increased by DKK 4,143 (USD $644) compared to the previous valuation of however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 13.19 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 13.19. The average price that AMP.MI shares were previous bought at was EUR 20.2713. The current market price is -34.9% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 7,766 (USD $9,015) compared to the previous valuation of Amplifon SpA |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 781.4 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 781.4. The average price that ARGX.BR shares were previous bought at was EUR 508.161. The current market price is 53.8% higher than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 239,375 (USD $277,858) compared to the previous valuation of Argenx SE however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 156.976 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 156.976. The average price that AZN.L shares were previous bought at was GBP 125.063. The current market price is 25.5% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 452,487 (USD $597,706) compared to the previous valuation of AstraZeneca PLC |
| BAVA.CO - | HOLD | 0 @ DKK 25.7344 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 25.7344. The average price that BAVA.CO shares were previous bought at was DKK 22.8997. The current market price is 12.4% higher than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 21,606 (USD $3,358) compared to the previous valuation of however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 34.15 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 34.15. The average price that BAYN.DE shares were previous bought at was EUR 25.4056. The current market price is 34.4% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 1,536,982 (USD $1,784,077) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 107.7 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 107.7. The average price that BIM.PA shares were previous bought at was EUR 119. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 16,448 (USD $19,092) compared to the previous valuation of BioMerieux |
| CAMX.ST - | HOLD | 0 @ SEK 54.6203 | SEK 0 | |
| COLO-B.CO - | HOLD | 0 @ DKK 77.3102 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 77.3102. The average price that COLO-B.CO shares were previous bought at was DKK 86.1309. The current market price is -10.2% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 103,637 (USD $16,109) compared to the previous valuation of |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.63902 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.63902. The average price that CTEC.L shares were previous bought at was GBP 3.26342. The current market price is -19.1% lower than average price they were purchased at. The value of the holding in CTEC.L has fallen by GBP 32,180 (USD $42,508) compared to the previous valuation of ConvaTec Group PLC |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 101.6 | EUR 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 61.2 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 61.2. The average price that DIA.MI shares were previous bought at was EUR 95.1491. The current market price is -35.7% lower than average price they were purchased at. The value of the holding in DIA.MI has fallen by EUR 1,324 (USD $1,537) compared to the previous valuation of DiaSorin SpA |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 207.4 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 207.4. The average price that DIM.PA shares were previous bought at was EUR 198.449. The current market price is 4.5% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 8,217 (USD $9,538) compared to the previous valuation of Sartorius Stedim Biotech |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 307.4 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 307.4. The average price that EL.PA shares were previous bought at was EUR 248.629. The current market price is 23.6% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 53,220 (USD $61,776) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 59.36 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 59.36. The average price that ERF.PA shares were previous bought at was EUR 57.9209. The current market price is 2.5% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 20,141 (USD $23,379) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 40.9 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 40.9. The average price that FME.DE shares were previous bought at was EUR 47.8642. The current market price is -14.5% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 16,959 (USD $19,685) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 46.86 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 46.86. The average price that FRE.DE shares were previous bought at was EUR 42.5137. The current market price is 10.2% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 85,821 (USD $99,618) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 169.308 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 169.308. The average price that GALD.SW shares were previous bought at was CHF 119.169. The current market price is 42.1% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 7,587 (USD $9,430) compared to the previous valuation of |
| GETI-B.ST - | HOLD | 0 @ SEK 19.3293 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 19.3293. The average price that GETI-B.ST shares were previous bought at was SEK 17.2685. The current market price is 11.9% higher than average price they were purchased at. The value of the holding in GETI-B.ST has fallen by SEK 34,383 (USD $3,638) compared to the previous valuation of |
| GMAB.CO - | HOLD | 0 @ DKK 272.34 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 272.34. The average price that GMAB.CO shares were previous bought at was DKK 186.369. The current market price is 46.1% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 32,733 (USD $5,088) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.43 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.43. The average price that GRF.MC shares were previous bought at was EUR 10.3964. The current market price is 0.3% higher than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 9,395 (USD $10,905) compared to the previous valuation of Grifols SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 20.6913 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 20.6913. The average price that GSK.L shares were previous bought at was GBP 16.9988. The current market price is 21.7% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 311,851 (USD $411,935) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 17.9499 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.9499. The average price that HIK.L shares were previous bought at was GBP 23.9671. The current market price is -25.1% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 180 (USD $238) compared to the previous valuation of however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |